Description
Recombinant monoclonal antibody to CD63. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma NK-1-C3. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
CD63
Target Alias Names
Granulophysin, LAMP-3, Tetraspanin-30, Tspan-30, Lysosomal-associated membrane protein 3, Melanoma-associated antigen ME491, OMA81H, Ocular melanoma-associated antigen, CD63 antigen, NK1/C3, NKI/C3, NK-1.C3, NK1C3
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression